China Pharma (NYSE:CPHI) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of China Pharma (NYSE:CPHI) from a sell rating to a hold rating in a research report sent to investors on Wednesday morning.

China Pharma Price Performance

Shares of NYSE CPHI opened at $2.22 on Wednesday. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.79 and a quick ratio of 0.26. The company’s fifty day moving average price is $9.95 and its 200 day moving average price is $17.24. China Pharma has a 1 year low of $1.20 and a 1 year high of $3.35.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.